Monoclonal Antibodies: A Good Place To Be In The Time Of Covid-19 And Stock Market BubblesSeeking Alpha • 09/15/20
Obsidian Therapeutics Announces Bristol Myers Squibb Opt-In of cytoDRiVE™ Cell Therapy CandidatePRNewsWire • 09/15/20
European Medicines Agency Validates Bristol Myers Squibb’s Type II Variation Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for First-line Treatment of Malignant Pleural MesotheliomaBusiness Wire • 09/15/20
Daily Dividend Report: AbbVie, Bristol Myers Squibb, Colgate-Palmolive, American Tower, CernerForbes • 09/11/20
3 Incredibly Strong Stocks to Buy That Should Thrive Even If the Stock Market Crashes AgainThe Motley Fool • 09/11/20
Bristol Myers Squibb (BMY) Stock Moves -1.34%: What You Should KnowZacks Investment Research • 09/10/20
Bristol Myers Squibb to Participate in Morgan Stanley’s 18th Annual Global Healthcare Virtual ConferenceBusiness Wire • 09/10/20
Bristol-Myers Squibb Company (BMY) Management Presents at Citi 15th Annual Biopharma Conference (Transcript)Seeking Alpha • 09/09/20
Bristol Myers Squibb Research at ESMO Virtual Congress 2020 Highlights Significant Progress in Cancers with High Unmet Medical NeedBusiness Wire • 09/08/20
Bristol Myers Squibb (BMY) Stock Moves -0.17%: What You Should KnowZacks Investment Research • 09/04/20
Bristol Myers Squibb to Participate in Citi’s 15th Annual BioPharma Virtual ConferenceBusiness Wire • 09/02/20